AGP Executive Report
Last update: 9 hours agoPublic Health & Safety: NYC’s Upper East Side Legionnaires’ outbreak is declared over after seven deaths, but critics say enforcement gaps and late inspections left residents exposed longer than they should have been. Infectious Disease Watch: A CDC-linked report highlights the growing threat of drug-resistant Candida auris, with older, hospitalized patients most at risk and New York among the hardest-hit states. Food Safety: The FDA is investigating 10 foodborne outbreaks nationwide, a reminder for New Yorkers to watch recalls and safe handling. Clinical Innovation: Eli Lilly expands access to retatrutide for eligible, refractory obesity patients who can’t join trials, drawing mixed clinician reactions. Allergy Breakthrough: Kindred Companion Sciences says it created genetically edited dogs that don’t produce the major Can f 1 allergen, aiming to help dog-allergic families. Healthcare Costs & Coverage: CVS Health reported Q2 net income up to $2.9B as it gains control of Aetna costs, while New York continues to face affordability pressure in new studies. Policy & Access: Michigan AG Dana Nessel announced a $400M settlement with Sandoz over alleged generic-drug price and competition conspiracies.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
